ABSTRACT
INTRODUCTION
Since the first three cases of AIDS were identified in Kagera Region, Northwestern Tanzania in 1983, a rapid and relentless spread has taken the disease into every corner of the country. In 2001 the number of reported AIDS cases was 14,112, leading to projected countrywide cases at 71,000 (1) . Estimates of HIV infection rates in the population are based on surveillance of antenatal clinic attendees, blood donors and patients of sexually transmitted disease clinics. In 2001 the HIV seroprevalence among blood donors countrywide was estimated at 11.01% (1) . Of patients attending sexually transmitted diseases (STDs) clinic in Dar es Salaam, 44.2% of those who consented to HIV testing were positive (2) . A study involving Police officers in Dar es Salaam revealed HIV prevalence of 18% in females and 13.3% in males (3) . The seroprevalence among 800,000 women going to deliver at various health care facilities in the country was 13.3% (2) . Of consecutive febrile patients admitted to the medical wards at MNH in 1995, 55% were infected with HIV (4) .
The seroprevalence in blood donors is probably an under-representation of the seroprevalence in the general population because those who have the courage to "volunteer" to donate blood, where they know HIV screening will be done, may be a group with low risk factors for HIV infection. However, it is reasonable to assume that the nation-wide prevalence of HIV infection in the adult population during 2001-2002 will not exceed 13.3%, the seroprevalence in young sexually active women going to deliver at different health care facilities. Tanzania has an estimated 2.2 million persons of all ages living with HIV/AIDS(1). With a national population of 33 million people, the overall prevalence of HIV infection nationally is therefore 6.7%. There are marked differences in HIV seroprevalence in different parts of Tanzania, and among different population groups. It has been stated elsewhere in the past that urban prevalence rates are up to ten times higher than rural rates (5) . Collectively, the findings from these studies would seem to suggest a current prevalence of HIV infection nation-wide in adults of just over 10%. The Adult Morbidity and Mortality Study done in three settings in Tanzania has shown that HIV/AIDS is the leading cause of death among men aged 15 -59 years in two of the three study areas (6) .
HIV infection has been studied in different clinical settings at MNH. In hospitalised paediatric patients in a 1995-1996 study, the HIV seroprevalence was 19.2% (7) . In medical in-patients a seroprevalence of 35% in males and 38% in females was reported in 1992 (8) . In Obstetric patients at the antenatal clinic the seroprevalence in a 1996 -1998 study was 13.7%(9) and in psychiatric in-patients the seroprevalence was estimated at 22% (10) . To date there has been no similar study in general surgery. HIV infection in surgical patients is a matter of special interest because of its influence on the clinical presentation of various surgical diseases, the increased prevalence of conditions like atypical Kaposi's sarcoma, lymphomas, pyomyositis, empyema thoracis and various malignancies in HIV infected persons. It has been suggested that prostate cancer may be more common in patients with HIV/ AIDS than in the general population (11) . Aggressive cutaneous squamous cell carcinomas have been reported in young HlV-infected people (12) .
The potential risk of transmission from patients to staff is another area of considerable interest and controversy. Many diagnostic and therapeutic manoeuvres in clinical surgery carry a potential for contamination and infection of staff by blood and other body fluids that has no parallel in the non-surgical medical disciplines (13) . Blood and potentially contaminated body fluids in urological surgery and the risk they pose to the surgeon deserve special attention (14) . The range of attitudes of surgeons towards HIV infection in patients and health care workers (HCW's) is wide, and opinions vary, including surgeons' refusal to operate on seropositive patients and recommendation to bar infected surgeons from operating. Considerable controversy exists on the risk of seroconversion in the absence of antiretroviral prophylaxis in the HCW following a solid needle-stick injury during surgery on an HIV infected patient, but it is believed to be of the order of 0.3% (13, 15) .
A Democratic Republic of Congo study showing similar trends of infection in surgical, nursing and administrative staff at the Mama Yemo Teaching Hospital supports the conclusion that the risk of transmission from patient to surgeon is low (15) . The patient's viral load, which depends on the disease stage, is one of the factors influencing this risk (13, 16) . It is therefore of interest to study the prevalence of HIV infection and the pattern of presentation in surgical patients at this point in time in the course of the epidemic in this area of high HIV prevalence.
Objectives: To determine the prevalence of HIV infection in newly hospitalised surgical patients at Muhimbili National Hospital (MNH), its relationship to various socio-demographic features of the patients and to various surgical conditions.
MATERIALS AND METHODS
Study subjects: All new patients being admitted to the paediatric (1-10 years of age) and adult surgical wards between December 2001 and February 2002 were recruited into the study. The majority of MNH admissions originated from Dar es Salaam (a city of about 3 million inhabitants) and its surroundings, but some came as referrals from upcountry. MNH has 1400 beds, of which 230 are for Paediatric and adult General Surgery.
Demographic and clinical Bio-data collection: On admission patients were informed of the ongoing study, enrolled, interviewed and examined by an attending doctor. A nurse with training and experience in HIV counselling privately counselled each patient for HIV testing. In the case of children or unconscious patients a parent or accompanying person was interviewed. The information recorded on a questionnaire for each patient included the patient's personal particulars, relevant symptoms and signs, medical history, education level, marital status, discharge diagnosis and final disposal of the patient. The record also indicated whether the patient consented to HIV testing, the test result for those who consented, and results of sputum examination for acid fast bacteria.
HIV testing: Consenting patients had blood drawn for HIV serology. HIV testing was by dual ELISA strategy done sequentially. The first ELISA was Enzygnost anti HIV1/2 Plus (Dade Behring, Marburg, Germany) and the second ELISA was Welcozyme HIV Recombinant (Abbott Murex, Dartford, UK). Samples reactive on both assays were considered seropositive for HIV antibodies. Samples that were non reactive on the first assay were reported as HIV seronegative. Repeatedly discordant samples were confirmed by Western blot. Interpretation of Western blot reactivity was done according to the World Health Organization criteria (17) .
The data were coded, entered, cleaned and analysed using EPIINFO software (Centres for Disease Control, Atlanta, Georgia) according to the study objectives. As individual diagnoses were found to be too numerous, diagnoses were combined into diagnostic groups to facilitate analysis. Differences between proportions were assessed using the x 2 test, confidence intervals were calculated using the Fleiss quadratic approximation formula and are reported at 95% level.
Ethical issues: Written consent was obtained from all study subjects before recruitment. Pre-test counselling was done for those agreeing to HIV testing, followed by posttest counselling for those opting to receive their results. Ethical clearance for the study was obtained from the Muhimbili College Ethical Committee. HIV test results were handled confidentially.
RESULTS
The study was conducted over three months from December 2001 to February 2002 during which time 1,534 patients were admitted to the surgical wards. Of these, 1030 were male (67.1 %) and 504 were female (32.9%). Following counselling, 672 men (65.2%) consented to HIV testing while 359 women (71.2%) consented, giving an overall consent rate of 67.2%.
Of 1031 patients who consented to HIV testing, 11% of the males were seropositive while 13.9% of female patients were seropositive (p=0.1). The age adjusted prevalence of HIV infection was found to be 10.5%.
The age and sex specific HIV seroprevalence is shown in (Figure 1 ). Below 24 years of age those infected were predominantly female, as were those above 55 years, while between 25 and 54 years of age, more males than females were infected. Even when the zero to four year age group (prevalence = 0) is excluded, the difference in HIV prevalence between various age groups was statistically significant (p< 0.0001).
Of all patients above the age of 15 years who were tested for HIV antibodies (n=711), divorced and widowed patients had HIV seroprevalence rates of 20.6% and 18.4% respectively, compared to married and single patients whose HIV seroprevalence rates were 15.5% and 13.4% respectively. The difference in HIV seroprevalence between the different marital status groups were not statistically significant (p=0.5). No association was found between patient's education level and HIV status.
Of the 1031 patients who were tested for HIV antibodies, the HIV seroprevalence in Christians (n=589) and Moslems (n=424), the main groups, were 12.3% and 11.1% respectively. The difference was not statistically significant (p=0.52). Table 1 shows the prevalence of HIV infection in conditions traditionally associated with HIV infection/ AlDS. Patients presenting with stab wounds and those with breast cancer also had high prevalence of HIV infection. Total 1031 124
The prevalence of HIV infection among patients with suppurative and granulomatous infections was higher than that of other diagnostic groups (p<0.001). Age and Sex specific HIV prevalence among hospitalised surgical patients
Figure 2
Response to counselling for HIV testing by age groups among newly hospitalised surgical patients Table 2 shows the serostatus of patients by diagnostic groups. When diagnoses were grouped into broad categories, the highest HIV prevalence was among patients with suppurative and granulomatous infections (28.3%). The lowest prevalence was among patients with congenital anomalies (0%), obstructive uropathies (3.8%), and trauma (6.1%). Figure 2 demonstrates that between 15 and 34 years of age, which includes the majority of HIV infections, just over 50% of patients gave consent for HIV testing. In those below 15 years, in the majority of whom a parent or guardian was involved in counselling, and in whom HIV seroprevalence was low, over 80% gave consent. In patients aged 35 years or older the proportion consenting to testing increased with age from 62.4% to 72.9%. Table 3 shows a comparison of the prevalence of symptoms and signs associated with AIDS, and mortality in patients who were HIV tested, patients who declined to be tested, and in the study population as a whole.
Patients who declined to be tested had features similar to those of HIV negative patients.
Sixteen patients with productive cough submitted three consecutive sputum specimens each for Z-N stain, and three of the patients were found to have smear positive sputum for acid-fast bacteria.
DISCUSSION
HIV disease has become a clinical, social, economic and public health problem of enormous proportions in many countries of the world, especially in sub-Saharan Africa. For this study the college ethical clearance committee required that patients be counselled before testing for HIV antibodies, unlike some years ago when testing could be done without having to get patients' consent, provided the unlinked anonymous strategy was adopted (7,18) . The 67.2% of patients who agreed to take the HIV test were a higher proportion than that in counselled clients nation-wide whereby of 6,539 counselled in 2000, only 51% consented to HIV testing (2) .
In an earlier study in a rural setting in Northwestern Tanzania 55.9% of those counselled agreed to be tested (18) , while in a study of pregnant women attending antenatal clinics in Dar es Salaam 76.4% agreed to be tested. The higher testing rate in the latter study might be explained by the fact that the study was connected with an ongoing antiretroviral prophylaxis study to prevent mother to child HIV transmission (9) .
HIV/AIDS in our socio-cultural setting continues to be highly stigmatised, and the need to improve counselling has been noted before (9, 19) . The stigma around HIV/AIDS is further demonstrated by the fact that in the study by Kilewo et al, only 16.7% of the enrolled seropositive women were prepared to disclose their serostatus to their sexual partners (9) . By comparison, at a San-Francisco hospital, 99.5% of hospitalised Orthopaedic patients consented to HIV antibody testing (20) . However, the stigma of HIV infection is by no means confined to developing countries (21) .
Most studies in Tanzania show peak prevalence of HIV infection in the age group 25-34 years or younger (1, 2, 18) . In a study relating viral load to transmission in Uganda it was shown that the highest incidence of seroconversion was in the age group 15-19 years (22) , which suggests peak prevalence in a younger age group than usual. These findings contrast with those in the present study in which peak prevalence was in the age group 35-44 years at 27.9%, but the 25-34 year age group was a close second at 26.8% (Figure 1) .
HIV transmission in this part of the world is known to be mainly by heterosexual intercourse (1, 2, 22, 23) . A high seroprevalence in divorced and widowed patients may be due to increased high-risk sexual behaviour in adults forced by circumstances to be without their marriage partners. Widowed patients could, indeed, have lost their spouses to AIDS. However, the differences in seroprevalence between the different marital status groups did not reach statistical significance. A study in elderly medical patients at MNH also showed no difference in prevalence according to marital status. The same study showed no association in seroprevalence with urban versus rural residence, education level or socio-economic status (24) .
Religious affiliation did not show any association with HIV serostatus. Presumably sexual behaviour is guided more by socio-cultural norms than religious and moral ethics.
The sample size for the study was determined under the assumption of a seroprevalence rate of 30-40% as seen in medical wards at MNH. The unexpectedly low seroprevalence led to the relatively small numbers of seropositive patients in any given clinical condition. With these limitations in mind the majority of patients with tuberculous cervical lymphadenitis, anal fissure or fistula, abscesses and Kaposi's sarcoma were seropositive, while there was also a high prevalence in patients with empyema thoracis, primary peritonitis, pyomyositis, and breast cancer. At first sight it may seem curious that patients presenting with stab wounds had high HIV prevalence. It can be postulated that these young individuals involve themselves in rows and other socially dangerous situations, and that the same character traits expose them to high risk sexual behaviour leading to HIV infection. A study by Amir et al (25) from Muhimbili National Hospital suggested that HIV seroprevalence was low in patients with breast cancer, a finding that is not supported by the results of the present study (Table 1 ).
Of 1031 HIV tested patients, 20 of 124(16.1%) seropositive patients died in hospital while of 907 seronegative patients, 58(6.4%) died in hospital (p=0.0001, relative risk 2.5). The mortality of seropositive surgical inpatients in this study is lower than that found in seropositive paediatric patients at MNH of 21.4% (7) . Patients with suspected pulmonary tuberculosis without a surgical disease are normally taken into the medical wards. Thus a relatively small number of patients in this study were tested for acidfast bacteria and only three of them had positive smears.
It is tempting to speculate that the patients who declined to be tested for HIV infection were those at high risk of being HIV positive. However, the prevalence of diarrhoea, productive cough, fever and weight loss, symptoms that are common in AIDS patients, was comparable in patients who declined HIV testing and patients who were HIV seronegative, but significantly lower than in HIV seropositive patients.
As shown in Table 3 , the same trend is observed when the prevalence of physical signs commonly found among patients with AIDS are compared. Comparison of the hospital mortality in the four groups again shows that the untested patients had similar mortality to the seronegative patients but that these were significantly lower than in the seropositive group (p<0.0001). These findings suggest that the patients who declined to undergo HlV-testing were simply patients who did not want to be bothered with another blood test and were not a high-risk group for HIV infection/AlDS.
CONCLUSION
In this study involving hospitalised surgical patients, the overall age-adjusted HIV seroprevalence of 10.5% was lower than expected in comparison to findings from similar studies in other hospital departments, but patients in the 14-25 years age groups had seroprevalence rates of 26.8-27.9%. The majority of patients with tuberculous lymphadenitis, anal fissure or fistula, stab wounds, abscesses and Kaposi's sarcoma were HIV positive. Interestingly, patients who declined to be tested for HIV antibodies had clinical features comparable to the HIV negative patients. HIV positive patients had significantly higher hospital mortality than those who were HIV negative.
